CombiMatrix has named Ronald Wapner, a physician and specialist in reproductive genetics, to serve on its scientific advisory board. Wapner is vice chair for research in obstetrics and gynecology for Columbia University Medical Center and director of reproductive genetics. He also was principal investigator for a National Institute of Child Health and Human Development-sponsored multi-center study comparing chromosomal microarray testing to karyotyping (BAN 2/14/2012).
Diagenic said this week that CEO Erik Christensen has resigned from his position, and the company has named Henrik Lund, chairman of the board of directors, to step in as interim CEO. Lund has left his position on the board to Ingrid Wiik, who is deputy chairman of the board, until the annual general meeting in June. Christensen had been CEO since 2007.